Healthcare and Life Sciences in North America: Opportunities & Post-Pandemic Outlook Dec 12, 2022 Life Science
RepliCel Ships DermaPrecise(TM) Injector Prototypes and Consumables to Independent Laboratory for Clinical Simulation Testing Nov 11, 2021 Life Science
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team Nov 9, 2021 Life Science
Looking for your next +30% opportunity? Join our multi-sector high growth stock virtual event Oct 27, 2021 Cannabis, Consumer Goods, Life Science, Technology
Hemostemix Confirms OTCQB Application is Filed Oct 19, 2021 Cannabis, Consumer Goods, Life Science, Technology
RepliCel Files Notice of Arbitration against Shiseido Company to Resolve its License Agreement Dispute Regarding its Androgenetic Alopecia Cell Therapy Oct 18, 2021 Cannabis, Consumer Goods, Life Science, Technology
Hemostemix Announces Dr. Fraser C. Henderson Sr., MD, as Chief Medical Officer Oct 14, 2021 Cannabis, Consumer Goods, Life Science, Technology
RepliCel Life Sciences Appoints One of Japan’s Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor Oct 12, 2021 Cannabis, Consumer Goods, Life Science, Technology
Hemostemix Announces the Second Stem Cell Recipient Interview: One Week to No Chest Pain Oct 4, 2021 Cannabis, Consumer Goods, Life Science, Technology
